多囊卵巢综合征伴肥胖及高胰岛素血症女性果糖水平升高
该研究纳入157名中国汉族女性(67名对照、90名PCOS患者),检测血清及卵泡液中果糖水平。结果显示,超重/肥胖及高促卵泡刺激素(FSI)的PCOS患者血清果糖升高,果糖联合总睾酮对PCOS有较高预测价值;PCOS患者卵泡液果糖水平也高于对照。
要点
- 超重/肥胖PCOS患者血清果糖升高, cutoff 10.13 pmol/μl时AUC 79.7%。
- 高FSI组果糖 cutoff 10.49 pmol/μl时AUC 72%。
- 果糖联合总睾酮预测超重/肥胖PCOS的AUC达86.0%。
核心结论
- 在中国汉族超重/肥胖及高胰岛素血症女性中,血清果糖升高与PCOS相关。
- PCOS患者卵泡液果糖水平高于对照,无论卵泡成熟与否。
研究设计与样本
- 在中国医科大学盛京医院招募157名中国汉族女性(67名对照、90名PCOS患者)。
- 血清果糖检测纳入80例PCOS(32例瘦、48例超重/肥胖)和59例对照(27例瘦、32例超重/肥胖)。
- 卵泡液检测来自10例PCOS和8例对照的成熟卵泡(17-22 mm)及匹配的未成熟卵泡(8-13 mm)。
主要发现
- 超重/肥胖和高FSI的PCOS患者血清果糖水平高于对照。
- 超重/肥胖组果糖预测PCOS的AUC为79.7%, cutoff 10.13 pmol/μl,灵敏度91.7%,特异度59.3%。
- 高FSI组果糖预测PCOS的AUC为72%, cutoff 10.49 pmol/μl,灵敏度71.1%,特异度64.4%。
- 超重/肥胖组果糖联合总睾酮预测PCOS的AUC为86.0%,灵敏度85.4%,特异度83.1%,PPV 80.4%,NPV 87.5%。
- 高FSI组果糖联合总睾酮预测PCOS的AUC为80.2%,灵敏度73.3%,特异度84.7%,PPV 78.6%,NPV 80.6%。
关键数值与推荐
- 超重/肥胖组果糖 cutoff 10.13 pmol/μl,AUC 79.7%,灵敏度91.7%,特异度59.3%。
- 高FSI组果糖 cutoff 10.49 pmol/μl,AUC 72%,灵敏度71.1%,特异度64.4%。
- 超重/肥胖组果糖联合总睾酮AUC 86.0%,灵敏度85.4%,特异度83.1%。
- 高FSI组果糖联合总睾酮AUC 80.2%,灵敏度73.3%,特异度84.7%。
临床怎么用
- 对超重/肥胖或高胰岛素血症的PCOS疑似患者,可考虑检测血清果糖辅助预测。
- 果糖联合总睾酮可提高对超重/肥胖及高FSI人群PCOS的预测效能。
局限性
- 尚不清楚果糖是直接参与卵泡发育和PCOS发病,还是仅为生物标志物。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Are fructose levels altered in women with polycystic ovary syndrome (PCOS)? SUMMARY ANSWER: Elevated serum fructose levels are associated with PCOS in Chinese Han women with overweight/obesity and hyperinsulinemia, and fructose levels are higher in follicular fluids from PCOS patients than from control subjects. WHAT IS KNOWN ALREADY: Both fructose levels and PCOS are closely linked to obesity and insulin resistance. However, the relationship between fructose and PCOS remains largely unknown. STUDY DESIGN, SIZE, DURATION: A total of 157 Chinese Han women (67 controls and 90 PCOS patients) were recruited at Shengjing Hospital of China Medical University. To systematically study the relationship between serum fructose levels and PCOS, the study population of control subjects and PCOS patients was divided into overweight/obese and lean subgroups, and hyper-fasting serum insulin (FSI) and normal-FSI subgroups, respectively. PARTICIPANTS/MATERIALS, SETTING, METHODS: Fructose levels were measured in serum samples collected from 80 patients with PCOS (32 lean, 48 overweight/obese) and 59 control subjects (27 lean, 32 overweight/obese) and in follicular fluid samples collected from mature follicles (17-22 mm) and matched immature follicles (8-13 mm) from 10 patients with PCOS and 8 control subjects. MAIN RESULTS AND THE ROLE OF CHANCE: Serum fructose levels were increased in overweight/obese and hyper-FSI PCOS patients compared with the control subjects. Fructose had an area under the curve (AUC) of 79.7% at a cutoff value of 10.13 pmol/μl, with a sensitivity of 91.7% and a specificity of 59.3% for the prediction of PCOS in overweight/obese patients. In the hyper-FSI group, fructose had an AUC of 72% at a cutoff value of 10.49 pmol/μl, with a sensitivity of 71.1% and a specificity of 64.4% for the prediction of PCOS. There were no differences between fructose, total testosterone, free testosterone or dehydroepiandrosterone sulfate levels with respect to the reliability of predicting PCOS in the overweight/obese or hyper-FSI groups using the method outlined by Hanley and McNeil. Notably, the combination of fructose and total testosterone levels resulted in the highest AUC of 86.0% and high sensitivity (85.4%) and specificity (83.1%) for the prediction of PCOS in overweight/obese patients. The positive predictive value (PPV) and negative predictive value (NPV) were 80.4 and 87.5%, respectively. Similarly, the combination of fructose and total testosterone levels also resulted in a high AUC of 80.2% and moderate sensitivity (73.3%) and high specificity (84.7%) for the prediction of PCOS in hyper-FSI patients. The PPV and NPV were 78.6 and 80.6%, respectively. Furthermore, fructose levels were significantly higher in follicular fluids from PCOS patients than from control subjects, regardless of whether the follicles were mature or immature. LIMITATIONS, REASONS FOR CAUTION: It remains unclear whether fructose levels contribute directly to follicular development and the pathogenesis of PCOS or are merely a biomarker of these processes. WIDER IMPLICATIONS OF THE FINDINGS: The results of the present study, together with our previous study, show that monosaccharide status may be a novel marker for PCOS, highlighting the importance of further investigation into the role of monosaccharides, especially fructose, in the pathogenesis of PCOS. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by the National Natural Science Foundation of China (No. 81671423 and No. 81402130), the National Key Research and Development Program of China (No. 2018YFC1003100), Liaoning Provincial Key Research and Development Program (No. 2018225090), the Fok Ying Tung Education Foundation (No. 151039), Distinguished Talent Program of Shengjing Hospital (No. ME76) and Distinguished Teacher Program of China Medical University (No. QGZ2018079). No competing interests were declared.
引用
- Shi B, Feng D, Sagnelli M, et al. Fructose levels are elevated in women with polycystic ovary syndrome with obesity and hyperinsulinemia. Hum Reprod. 2020. PMID: 31943006. doi:10.1093/humrep/dez239
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。